Search Menu

Balancing futility and benefit – Is academic research ready for higher research quality standards?

byAnton Bespalov (PAASP)Adrian G. Barnett (Queensland University of Technology, Brisbane, Australia)C. Glenn Begley (BioCurate, Melbourne, Australia) *For a condensed version of this commentary, please visit the Nature website.  Many of the signals of concern about the current research system originate from industry and are not always positively received by …

Read more

How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation

Reproducibility in preclinical research may be low because of the high prevalence of biases and of suboptimal research practices (such as biased allocation of experimental groups, experimenter bias and lack of necessary controls, the use of uncharacterized materials, poor use of statistics, poor scientific training, etc.). …

Read more

PDN Training Workshop

Feb 27 – Mar 1, 2019 (Athens, Greece)“How to Make Preclinical Research Robust”2nd Preclinical Data Network Training Workshop for Young ScientistsCoordinators (Europe): Anton Bespalov (PAASP), Thomas Steckler (Janssen)Coordinators (North America): Magali Haas, Patricia Kabitzke, Chantelle Ferland-Beckham (Cohen Veterans Bioscience)Local organizers: Christina Dalla, Nikolaos Kokras (National and Kapodistrian …

Read more

Scroll Up